14.1 Venous Leg Ulcers, Chronic Venous Insufficiency & Compression

14.1 Venous Leg Ulcers, Chronic Venous Insufficiency & Compression

Core Clinical Principle: Chronic Venous Insufficiency (CVI) is a hemodynamically driven disorder characterized by persistent ambulatory venous hypertension. Venous leg ulcers (VLUs) represent the end-stage cutaneous manifestation of this hypertension, accounting for 70% to 80% of all lower extremity ulcerations. Definitive healing requires counteracting hydrostatically elevated transmural pressures through graduated compression therapy while eliminating underlying superficial reflux through early endovenous ablation.

Venous return from the lower extremities against gravity depends on a tripartite physiological system: the patency of deep conducting veins, competent unidirectional bicuspid venous valves, and an effective musculoskeletal pump (predominantly the calf muscle gastroc-soleus complex). Breakdown of any component triggers a cascade of microvascular dysfunction, chronic inflammation, dermal remodeling, and eventual tissue ulceration.

---

Venous System Anatomy & Hemodynamic Principles

The lower extremity venous architecture is divided into three interconnected systems separated by deep muscular fascia:

1. Deep Venous System:
   • Vessels: Anterior tibial, posterior tibial, peroneal, popliteal, femoral, and deep femoral (profunda femoris) veins.
   • Physiology: Situated subfascially within muscular compartments; carries 85% to 90% of total venous outflow back to the inferior vena cava.
   • High-Pressure Reservoir: Intermittent contraction of surrounding muscle generates transient peak pressures exceeding 200 mmHg during vigorous locomotion.
2. Superficial Venous System:
   • Vessels: Great saphenous vein (GSV; originating anterior to the medial malleolus and terminating at the saphenofemoral junction [SFJ] in the groin), Small saphenous vein (SSV; originating posterior to the lateral malleolus and terminating at the saphenopopliteal junction [SPJ]), and anterior/posterior accessory saphenous veins.
   • Physiology: Located in the epifascial subcutaneous plane; drains the cutaneous and subcutaneous microcirculation.
3. Perforating Veins (Perforators):
   • Vessels: Cockett (paratibial / medial calf), Boyd (paratibial knee), Dodd (distal thigh), and Hunterian (proximal thigh) perforators.
   • Physiology: Direct conduits that pierce the deep investing fascia, connecting superficial veins to deep veins.
   • Directional Flow: In normal health, one-way bicuspid valves allow blood to flow exclusively from the superficial system to the deep system, and from distal to proximal.

The Calf Muscle Pump & Ambulatory Venous Hypertension

In a standing, non-moving individual at sea level, the hydrostatic venous pressure in the dorsal foot and ankle veins equals the weight of the blood column extending from the right atrium down to the foot—typically 80 to 90 mmHg.

• Physiological Ambulation: During normal walking, contraction of the gastrocnemius and soleus muscles compresses the deep sinusoidal veins, forcefully ejecting blood cephalad through competent deep valves. Concurrently, competent perforator valves snap shut, preventing high pressure from venting backward into the superficial system. During muscle relaxation, deep venous pressure drops to near zero, drawing superficial blood into the deep conduits. In an individual with normal venous valves, walking rapidly lowers ankle venous pressure from 80–90 mmHg down to 15–25 mmHg within 7 to 10 strides. This normal phenomenon is termed ambulatory venous pressure reduction.
• Pathophysiological Failure: In CVI, valvular incompetence, deep outflow obstruction (post-thrombotic syndrome after DVT), or calf pump failure (ankle joint arthrosis, severe paresis) abolishes this pressure drop. Walking fails to decrease venous pressure, sustaining continuous ambulatory venous hypertension (60 to 90 mmHg) throughout the gait cycle.

Diagnostic Duplex Ultrasound Thresholds for Pathologic Reflux

Duplex ultrasonography is the noninvasive diagnostic gold standard for evaluating chronic venous disease. Reflux is evaluated with the patient standing or in steep reverse Trendelenburg position, using manual compression/release or rapid pneumatic cuff deflation:

DUPLEX ULTRASOUND VENOUS REFLUX CUTOFF THRESHOLDS
==================================================================================
Superficial Saphenous Veins (GSV, SSV, Accessories) : > 500 milliseconds (0.5 seconds)
Perforating Veins (Cockett, Boyd, Dodd)            : > 500 milliseconds (or > 350 ms)
Deep Conducting Veins (Femoral, Popliteal)          : > 1,000 milliseconds (1.0 second)
==================================================================================

Retrograde flow exceeding these precise temporal cutoffs signifies pathological valvular incompetence requiring intervention.

+-------------------------------------------------------------------------------------------------+
|                   CASCADE OF AMBULATORY VENOUS HYPERTENSION TO VLU                             |
+-------------------------------------------------------------------------------------------------+
| 1. MACROVASCULAR REFLUX / OBSTRUCTION                                                          |
|    • Superficial (GSV/SSV) reflux (>500 ms) + Deep reflux (>1000 ms) + Incompetent perforators |
|    • Loss of calf muscle pump efficiency -> Sustained ambulatory pressure (60-90 mmHg)         |
+-------------------------------------------------------------------------------------------------+
                                                │
                                                ▼
+-------------------------------------------------------------------------------------------------+
| 2. MICROVASCULAR TRANSMURAL TRANSMISSION                                                       |
|    • Retrograde pressure transmitted into post-capillary venules and dermal capillary loops     |
|    • Capillary dilation, extreme tortuosity, microvascular pooling, and endothelial distension |
+-------------------------------------------------------------------------------------------------+
                                                │
                                                ▼
+-------------------------------------------------------------------------------------------------+
| 3. LEUKOCYTE TRAPPING & ENDOTHELIAL DAMAGE                                                      |
|    • Shear-stress alteration upregulates ICAM-1, VCAM-1, and P-selectin on endothelium         |
|    • Margination, rolling, and adhesion of neutrophils and monocytes ('leukocyte trapping')   |
|    • Degranulation releases human neutrophil elastase, ROS, and MMP-1, 2, 8, 9, 12             |
+-------------------------------------------------------------------------------------------------+
                                                │
                                                ▼
+-------------------------------------------------------------------------------------------------+
| 4. DERMAL EXTRAVASATION & MACROMOLECULAR CUFFING                                                |
|    • Increased vascular permeability: Diapedesis of Erythrocytes and Fibrinogen into dermis    |
|    • Erythrocyte lysis -> Fe2+ release -> Ferritin & Hemosiderin uptake by dermal macrophages  |
|      --> Hemosiderin Staining & Stasis Dermatitis                                              |
|    • Fibrinogen polymerizes into insoluble Pericapillary Fibrin Cuffs                           |
|      --> Traps TGF-β, PDGF, and decorin, blocking reparative paracrine signaling               |
+-------------------------------------------------------------------------------------------------+
                                                │
                                                ▼
+-------------------------------------------------------------------------------------------------+
| 5. DERMAL LIPODERMATOSCLEROSIS & TISSUE NECROSIS                                                |
|    • Subcutaneous fat necrosis, chronic fibrosing panniculitis, transforming growth factor-β1  |
|    • Circumferential woody induration of distal calf ('Inverted Champagne Bottle' deformity)    |
|    • Microvascular infarction (Atrophie Blanche) -> Epidermal breakdown -> Active VLU (C6)     |
+-------------------------------------------------------------------------------------------------+

---

Cutaneous & Histopathological Manifestations

Ambulatory venous hypertension produces a stereotyped spectrum of progressive tissue transformations:

1. Stasis Dermatitis & Hemosiderin Hyperpigmentation

Continuous capillary distention forces erythrocytes out of the microcirculation into the papillary and reticular dermis via diapedesis. Dermal macrophages phagocytose extravasated red blood cells, catabolizing heme into ferritin and hemosiderin. Insoluble hemosiderin aggregates inside histiocytes and dermal collagen bundles, producing the classic golden-brown to dark-ochre pigmentation of the gaiter region. Concurrently, inflammatory cytokines stimulate epidermal spongiosis, scaling, erythema, and intense pruritus (stasis dermatitis).

2. Pericapillary Fibrin Cuffs

Microvascular hyperpermeability permits large plasma proteins, notably fibrinogen, to escape into the pericapillary interstitium. Extravasated fibrinogen polymerizes into dense, insoluble pericapillary fibrin cuffs. Historically, these cuffs were hypothesized to form an impermeable mechanical barrier to oxygen diffusion (the obsolete "fibrin cuff hypothesis"). Modern molecular biology demonstrates that oxygen readily diffuses across fibrin; rather, fibrin cuffs act as a macromolecular sink, binding and sequestering crucial reparative growth factors such as transforming growth factor-beta (TGF-β), platelet-derived growth factor (PDGF), and basic fibroblast growth factor (bFGF), rendering them bio-unavailable to host fibroblasts and endothelial cells.

3. Lipodermatosclerosis (LDS)

Lipodermatosclerosis (sclerosing panniculitis) is a chronic, progressive, fibrosing inflammation of the dermis and subcutaneous adipose tissue:

• Acute Phase: Characterized by severe localized pain, warmth, erythema, and tender induration of the medial lower leg, frequently misdiagnosed as acute bacterial cellulitis or superficial thrombophlebitis. Key distinguishing features: Acute LDS is often bilateral, lacks fever or leukocytosis, and fails to respond to oral antibiotics.
• Chronic Phase: Subcutaneous fat necrosis undergoes progressive organization and replacement by dense Type I collagenous scar tissue. The lower third of the leg becomes encased in a rigid, circumferential, non-yielding woody cylinder. Because proximal calf tissues retain soft tissue bulk while the supramalleolar ankle is constricted by fibrosis, the lower leg assumes the characteristic "inverted champagne bottle" or "piano leg" deformity.

4. Atrophie Blanche (White Atrophy)

Atrophie blanche represents focal, avascular dermal infarction. It manifests as smooth, ivory- or porcelain-white stellate atrophic plaques studded with tortuous, ectatic capillary loops (appearing as pinpoint red dots) and bordered by hyperpigmented hemosiderin halos. Lesions occur most commonly around the malleoli, are excruciatingly painful, and exhibit extreme susceptibility to breakdown into sluggish, slow-healing, exquisitely painful ulcerations.

5. Corona Phlebectatica Paraplantaris

A fan-shaped pattern of small intradermal telangiectasias located around the medial malleolus and arch of the foot (malleolar flare). It represents an early cutaneous warning sign of advanced underlying venous incompetence, formally incorporated into the revised CEAP classification as C4c.

---

The CEAP Classification System (Updated 2020 Revision)

The CEAP classification is the internationally accepted, consensus-standard framework for categorizing chronic venous disorders across four distinct domains: Clinical signs, Etiology, Anatomy, and Pathophysiology.

CEAP CLINICAL CLASSIFICATION (C0 - C6)
==================================================================================
C0 : No visible or palpable signs of venous disease
C1 : Telangiectasias (< 1 mm diameter) or reticular veins (1 to < 3 mm diameter)
C2 : Varicose veins (subcutaneous tortuous dilated veins >= 3 mm in upright position)
     • C2r : Recurrent varicose veins
C3 : Dependent edema of venous origin (ankle/foot; pitting, improves with elevation)
C4 : Changes in skin and subcutaneous tissue secondary to chronic venous disease:
     • C4a : Pigmentation (hemosiderin) and/or venous eczema (stasis dermatitis)
     • C4b : Lipodermatosclerosis (sclerosing panniculitis) and/or Atrophie blanche
     • C4c : Corona phlebectatica paraplantaris (fan-shaped ankle/foot telangiectasias)
C5 : Healed venous ulcer (skin intact with post-ulcer cicatrization)
C6 : Active venous leg ulcer (open, full-thickness cutaneous defect in gaiter zone)
     • C6r : Recurrent active venous leg ulcer
==================================================================================

Etiologic, Anatomic, and Pathophysiologic Breakdown

• Etiology (E):
  • Ec: Congenital (e.g., Klippel-Trénaunay syndrome)
  • Ep: Primary (intrinsic degenerative valvular incompetence without preceding thrombosis)
  • Es: Secondary (post-thrombotic syndrome following deep venous thrombosis, trauma)
  • En: No venous cause identified
• Anatomy (A):
  • As: Superficial system (GSV, SSV, non-saphenous)
  • Ap: Perforating veins (thigh, calf)
  • Ad: Deep system (IVC, iliac, femoral, popliteal, tibial, muscular)
  • An: No venous anatomy identified
• Pathophysiology (P):
  • Pr: Reflux (retrograde flow: >500 ms superficial/perforator; >1000 ms deep)
  • Po: Obstruction (intraluminal thrombus or extraluminal compression, e.g., May-Thurner syndrome)
  • Pr,o: Combined reflux and obstruction
  • Pn: No venous pathophysiology identified

Example Clinical Board Designation: A patient presenting with an active medial calf ulcer following a previous iliofemoral DVT, with duplex demonstrating popliteal vein occlusion and GSV reflux, is classified as: $C_6, E_s, A_{s,d}, P_{r,o}$.

---

Clinical Phenotype of Venous Leg Ulcers vs. Other Lower Extremity Ulcers

---

Multilayer Compression Therapy: Biophysics & Clinical Protocols

Graduated compression therapy is the gold-standard conservative therapy for venous hypertension. It eliminates ambulatory venous hypertension by narrowing dilated vein diameters (which brings incompetent valve leaflets back into apposition), augmenting calf muscle pump ejection velocity, shifting fluid from the interstitial space into the microcirculation, and suppressing pro-inflammatory leukocyte activation.

The Biophysics of Compression: Laplace's Law

The sub-bandage interface pressure delivered to the limb is mathematically governed by Laplace's Law (the Thomas derivation):

$P = \frac{T \times N \times 4630}{C \times W}$

Where:

• $P$ = Sub-bandage interface pressure (in mmHg)
• $T$ = Tension applied to the bandage during application (in kilograms-force, kgf)
• $N$ = Number of bandage layers applied (e.g., 50% overlap yields 2 layers; 4-layer system yields cumulative layers)
• $4630$ = Dimensional conversion constant converting tension in kgf/cm into mmHg interface pressure
• $C$ = Circumference of the limb at the measurement level (in centimeters, cm)
• $W$ = Bandage width (in centimeters, cm)

CRITICAL CLINICAL DEDUCTIONS FROM LAPLACE'S LAW
==================================================================================
1. Inverse Circumference Relationship (P ∝ 1/C):
   For a constant tension and bandage width, interface pressure is INVERSELY
   proportional to limb circumference. Because the ankle has a smaller circumference
   than the calf, wrapping with uniform tension NATURALLY produces GRADUATED
   COMPRESSION (highest pressure at the ankle, lowest pressure at the calf)!

2. The Bony Prominence Danger:
   Over sharp convex bony radii (anterior tibial crest, prominent malleoli),
   the local anatomical radius approaches zero (C becomes very small)!
   Therefore, sub-bandage pressure rises sharply, risking localized skin
   necrosis and iatrogenic pressure ulcers.
   --> MANDATE: Always apply thick sub-bandage orthopedic padding to fill anatomical
       depressions, eliminate sharp contours, and protect bony prominences before
       applying tensioned layers.

3. Bandage Width Effect (P ∝ 1/W):
   Narrower bandages produce HIGHER pressure than wider bandages under identical tension.
   Never use narrow elastic strips around the calf or knee without recalibrating tension.
==================================================================================

Medical Compression Garment Classes

Medical compression devices and stockings are categorized into four standardized pressure classes (measured at the ankle):

Elastic vs. Inelastic Bandaging: Resting vs. Working Pressure

The clinical hemodynamic performance of compression depends on the elastic properties of the fabric:

• Elastic (Long-Stretch) Bandages (>100% extensibility):
  • Dynamic Property: Can stretch to more than double their original length.
  • High Resting Pressure, Low Working Pressure: Because of high elastomeric recoil, elastic bandages exert continuous inward force even when the patient is completely resting or sleeping (high resting pressure). During ambulation, the elastic fabric yields to expanding muscle, producing relatively little additional peak pressure (low working pressure).
  • Clinical Implications: Unsafe to leave on patients with underlying moderate-to-severe arterial ischemia; maintains continuous pressure during recumbency.
• Inelastic (Short-Stretch) Bandages (<100% extensibility; e.g., Unna's boot, Comprilan):
  • Dynamic Property: Offer minimal stretch when pulled.
  • Low Resting Pressure, High Working Pressure: When the patient is recumbent or sedentary, the relaxed bandage exerts negligible inward compressive force (low resting pressure), maximizing comfort and safety during sleep. When the patient stands and walks, the contracting calf muscle expands against the rigid, non-yielding fabric cylinder, generating transient, powerful spikes of interface pressure (high working pressure, 50–60 mmHg). This vigorously drives deep venous return and collapses incompetent perforators.
  • Clinical Implications: Highly effective in active, ambulatory patients; completely ineffective in immobile, bedridden patients whose calf muscles never contract!

---

Comparison of Major Compression Systems

---

Vascular Safety Thresholds & Contraindications

Applying compression to an extremity with compromised arterial circulation can induce catastrophic microvascular strangulation, ischemic skin necrosis, and limb amputation. Prior to applying any compression device, objective noninvasive arterial perfusion testing is mandatory:

ARTERIAL EVALUATION ALGORITHM FOR COMPRESSION THERAPY
==================================================================================
Ankle-Brachial Index (ABI) >= 0.80  (AND absolute ankle pressure >= 60-70 mmHg):
  --> FULL THERAPEUTIC COMPRESSION SAFE (30-40 mmHg at ankle).
  --> First-line: 4-layer elastic wrap, 2-layer cohesive, or Unna's boot.

Ankle-Brachial Index (ABI) 0.50 to 0.79:
  --> MIXED ARTERIAL-VENOUS DISEASE.
  --> Full compression CONTRAINDICATED; apply MODIFIED REDUCED COMPRESSION (20-30 mmHg).
  --> Prefer short-stretch / inelastic systems (low resting pressure) to protect microvasculature.
  --> Close monitoring for ischemic rest pain; urgent vascular surgery consultation.

Ankle-Brachial Index (ABI) < 0.50  OR  Absolute Ankle Pressure < 60 mmHg:
  --> SEVERE PERIPHERAL ARTERIAL DISEASE / CHRONIC LIMB-THREATENING ISCHEMIA.
  --> COMPRESSION THERAPY IS ABSOLUTELY CONTRAINDICATED!
  --> Immediate revascularization required; compression will precipitate ischemic gangrene.

ABI > 1.30 (Incompressible, Calcified Vessels; e.g., Diabetes, ESRD):
  --> ABI IS UNRELIABLE due to Mönckeberg medial calcinosis.
  --> Must obtain Toe-Brachial Index (TBI; normal >= 0.70; interpret with toe pressures and clinical findings)
      or Skin Perfusion Pressure (SPP >= 40 mmHg) / TcPO2 (>= 30-40 mmHg).
==================================================================================

Other Absolute Contraindications to Compression

1. Decompensated Acute Congestive Heart Failure (NYHA Class III/IV): Mobilizing large volumes of sequestered lower extremity interstitial fluid back into the central venous circulation can precipitate acute flash pulmonary edema and cardiogenic shock.
2. Acute Untreated Deep Venous Thrombosis (DVT): Risk of mechanically dislodging thrombus and causing pulmonary embolism (PE); compression may be initiated once therapeutic anticoagulation is established and acute pain/edema allow.
3. Severe Uncontrolled Acute Bacterial Cellulitis / Phlegmasia Cerulea Dolens: Severe local infection and compartment-threatening venous thrombosis require immediate systemic treatment before bandaging.

---

Endovascular Interventions & The Landmark EVRA Trial

Historically, venous ulcer management relied exclusively on conservative compression bandaging, with surgical or endovascular interventions reserved for post-healing reflux elimination. This clinical paradigm was overturned by the landmark EVRA (Early Venous Reflux Ablation) Trial.

Modern Superficial Interventions

Superficial venous reflux (most commonly originating in the GSV, anterior accessory saphenous vein, or SSV) can be permanently eradicated via minimally invasive outpatient modalities:

• Thermal Ablation: Endovenous Laser Ablation (EVLA) or Radiofrequency Ablation (RFA) delivering thermal energy to denature collagen and induce fibrotic occlusion of the incompetent saphenous vein.
• Non-Thermal, Non-Tumescent (NTNT) Modalities: Ultrasound-Guided Foam Sclerotherapy (UGFS; using polidocanol or sodium tetradecyl sulfate), Cyanoacrylate adhesive glue (VenaSeal), or Mechanochemical ablation (MOCA / ClariVein).

The EVRA Trial (Gohel et al., New England Journal of Medicine, 2018)

• Study Design: Multicenter randomized controlled trial of 450 patients with venous leg ulcers of less than 6 months' duration and superficial venous reflux.
• Comparison Arms:
  1. Early Intervention Arm: Underwent endovenous ablation of superficial reflux within 2 weeks of presentation PLUS multilayer compression therapy.
  2. Delayed Intervention Arm: Treated with compression therapy alone, with ablation considered after the ulcer healed, or at least 6 months after randomization if it had not healed.
• Primary & Secondary Outcomes:
  • Faster Time to Healing: Median time to complete ulcer healing was 56 days (95% CI: 49–70) in the early-intervention group compared to 82 days (95% CI: 69–92) in the delayed-intervention group ($p = 0.001$).
  • Higher Healing Rates: Ulcer healing rates at 24 weeks were significantly higher with early ablation (85.6% vs. 76.3%).
  • Long-Term Ulcer-Free Time: At 1 year, patients in the early ablation group enjoyed a significantly greater median ulcer-free time (306 days vs. 278 days; $p = 0.002$).
  • Long-Term Follow-Up (Gohel et al., JAMA Surgery 2020): Over up to 5 years, recurrences occurred less often with early ablation (0.11 vs. 0.16 per person-year), although time to first recurrence did not differ significantly. The earlier ESCHAR trial showed that superficial venous surgery reduced 4-year recurrence from 56% to 31%.

PRACTICE POINT: THE EVRA PARADIGM
==================================================================================
Venous ulcer management is NO LONGER "compression first, evaluate for ablation later."
The standard of care is early duplex ultrasound evaluation followed by
EARLY SUPERFICIAL VENOUS ABLATION (THE EVRA TRIAL USED 2 WEEKS) for
patients with active VLUs and anatomically amenable superficial reflux, delivered
concurrently with therapeutic multilayer compression therapy.
==================================================================================